Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Xinyuan Huakang Biotechnology is a specialized biotechnology firm based in China that focuses on the development of recombinant protein technologies, particularly humanized collagen. The company operates at the intersection of regenerative medicine and medical aesthetics, producing a variety of medical-grade dressings, functional skincare products, and bioactive materials. Their core expertise lies in the synthesis of Type III collagen, which is utilized for wound healing, post-operative recovery, and anti-aging treatments. Xinyuan Huakang maintains manufacturing facilities that comply with medical device standards to supply both clinical and consumer markets. The company is a key player in the regional Shanxi biotech cluster, contributing to the advancement of biomimetic materials for tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Xinyuan Huakang Biotechnology.